CLINICAL RESEARCH
QT-interval prolongation inright precordial leads
an additional electrocardiographic hallmark of Brugada syndrome
Maria Vittoria Pitzalis, MD, PhD* ,*,
Matteo Anaclerio, MD, PhD*,
Massimo Iacoviello, MD*,
Cinzia Forleo, MD, PhD*,
Pietro Guida, MS*,
Rossella Troccoli, MD*,
Francesco Massari, MD ,
Filippo Mastropasqua, MD,
Sandro Sorrentino, PhD*,
Andrea Manghisi, MS* and
Paolo Rizzon, MD*
* Institute of Cardiology, University of Bari, Bari, Italy
Centre of Innovative Technologies for Signal Detection and Processing, University of Bari, Bari, Italy
Cardiology "Salvatore Maugeri" Foundation, IRCCS Cassano, Cassano, Italy
Manuscript received March 25, 2003;
revised manuscript received June 6, 2003,
accepted July 1, 2003.
* Reprint requests and correspondence: Dr. Maria Vittoria Pitzalis, Institute of Cardiology-University of Bari, Piazza Giulio Cesare 11, 70124 Bari, Italy.
mariavittoria.pitzalis{at}cardio.uniba.it
OBJECTIVES: The aim of this study was to evaluate whether the occurrence of the Brugada Syndrome typical electrocardiogram (ECG) pattern (i.e., right bundle branch block, coved-type ST-segment elevation, and T-wave inversion in the right precordial leads) is characterized by a concomitant lengthening of QT intervals in the right precordial leads.
BACKGROUND: It has been suggested that the typical ECG pattern of Brugada syndrome is due to a decreased net inward current during phase 1 of the action potential, which also leads to its prolongation in the right epicardium.
METHODS: Thirty-two subjects (19 males) age 37 ± 15 years with a suspicious baseline ECG, or who were relatives of Brugada syndrome patients, underwent 12-lead ECG before and after the administration of flecainide.
RESULTS: The flecainide test was negative in 14 and positive in 18 subjects. After flecainide administration, the positive ECGs were characterized by a greater QT interval corrected for heart rate (QTc) prolongation in the right precordial leads than that in the negative ECGs (78.2 ± 35.5 ms vs. 22.0 ± 28.4 ms in V1 and 107.1 ± 43.8 ms vs. 26.7 ± 30.1 ms in V2; p < 0.01), whereas there was no difference in the QTc prolongation in the left precordial leads (55.2 ± 25.3 ms vs. 35.1 ± 28.1 ms in V5 and 53.1 ± 32.8 ms vs. 27.3 ± 22.4 ms in V6; p = NS).
CONCLUSIONS: In accordance with the electrophysiological background, the typical ECG pattern of Brugada syndrome is also characterized by a considerable prolongation of the QT interval in right precordial leads.
|
Abbreviations and Acronyms
| | AP | = action potential | | ICC | = intraclass correlation coefficient | | PCR | = polymerase chain reaction | | QTc | = QT interval corrected for heart rate | | ROC | = receiver operator characteristics | | SSCP | = single-strand conformation polymorphism |
|
This article has been cited by other articles:
|
|
|
|
 
S. Nagase, K. F. Kusano, H. Morita, N. Nishii, K. Banba, A. Watanabe, S. Hiramatsu, K. Nakamura, S. Sakuragi, and T. Ohe
Longer Repolarization in the Epicardium at the Right Ventricular Outflow Tract Causes Type 1 Electrocardiogram in Patients With Brugada Syndrome
J. Am. Coll. Cardiol.,
March 25, 2008;
51(12):
1154 - 1161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. P. Letsas, G. Gavrielatos, M. Efremidis, S. P. Kounas, G. S. Filippatos, A. Sideris, and F. Kardaras
Prevalence of Brugada sign in a Greek tertiary hospital population
Europace,
November 1, 2007;
9(11):
1077 - 1080.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Iacoviello, C. Forleo, P. Guida, R. Romito, A. Sorgente, S. Sorrentino, S. Catucci, F. Mastropasqua, and M. Pitzalis
Ventricular Repolarization Dynamicity Provides Independent Prognostic Information Toward Major Arrhythmic Events in Patients With Idiopathic Dilated Cardiomyopathy
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
225 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z.-S. Zhang, J. Tranquillo, V. Neplioueva, N. Bursac, and A. O. Grant
Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H399 - H407.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Poelzing, C. Forleo, M. Samodell, L. Dudash, S. Sorrentino, M. Anaclerio, R. Troccoli, M. Iacoviello, R. Romito, P. Guida, et al.
SCN5A Polymorphism Restores Trafficking of a Brugada Syndrome Mutation on a Separate Gene
Circulation,
August 1, 2006;
114(5):
368 - 376.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Aiba, W. Shimizu, I. Hidaka, K. Uemura, T. Noda, C. Zheng, A. Kamiya, M. Inagaki, M. Sugimachi, and K. Sunagawa
Cellular Basis for Trigger and Maintenance of Ventricular Fibrillation in the Brugada Syndrome Model: High-Resolution Optical Mapping Study
J. Am. Coll. Cardiol.,
May 16, 2006;
47(10):
2074 - 2085.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Castro Hevia, C. Antzelevitch, F. Tornes Barzaga, M. Dorantes Sanchez, F. Dorticos Balea, R. Zayas Molina, M. A. Quinones Perez, and Y. Fayad Rodriguez
Tpeak-Tend and Tpeak-Tend Dispersion as Risk Factors for Ventricular Tachycardia/Ventricular Fibrillation in Patients With the Brugada Syndrome
J. Am. Coll. Cardiol.,
May 2, 2006;
47(9):
1828 - 1834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Meregalli, A. A.M. Wilde, and H. L. Tan
Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more?
Cardiovasc Res,
August 15, 2005;
67(3):
367 - 378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, I. Gussak, H. LeMarec, K. Nademanee, A. R. Perez Riera, et al.
Brugada Syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
Circulation,
February 8, 2005;
111(5):
659 - 670.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Zipes
The year in electrophysiology
J. Am. Coll. Cardiol.,
April 7, 2004;
43(7):
1306 - 1314.
[Full Text]
[PDF]
|
|
|
|
